Abandoned AstraZeneca Compounds “Given” To U.K. R&D Academics
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca is giving 15 shelved compounds to U.K.-based academics in a collaboration funded by public money that may produce scientific breakthroughs along with thorny IP issues.